Recurrence rate of pterygium following surgical excision with intraoperative versus postoperative mitomycin-C

Journal of the College of Physicians and Surgeons Pakistan

Volumn 18, Issue 8, 2008, Pages 489-492

  Rahman, Atiya ^a,b   Yahya, Kamran ^a   Sharif ul Hasan, Khwaja ^a  

^a BAQAI MEDICAL UNIVERSITY   (Pakistan)

^b NONE

Author keywords

Bare scleral excision; Mitomycin C; Pterygium; Recurrence

Indexed keywords

MITOMYCIN C;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POSTOPERATIVE PERIOD; PTERYGIUM; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SCLERA DISEASE; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ALKYLATING AGENTS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PTERYGIUM; RECURRENCE; RISK FACTORS;

EID: 54349087997     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ahmad I, Untoo RA, Ahmad SS. Complications following use of intraoperative mitomycin-C in pterygium surgery. JK Science 2004; 6: 34-6.
2. Saleem M, Muhammad L, Zia-ul-Islam. Pterygium: an epidemiological study. Pak J Ophthalmol 2004; 20:17-22.
3. Donnenfeld ED, Perry HD, Fromer S, Doshi S, Solomon R, Biser S. Subconjunctival mitomycin-C as adjunctive therapy before pterygium excision. Ophthalmology 2003; 110:1012-6.
4. Oguz H, Basar E, Gurler B. Intraoperative application versus postoperative mitomycin-C eye drops in pterygium surgery. Acta Ophthalmol Scand 1999; 77:147-50.
5. Barraquer R. Updated management of limbal dystrophies and degenerations - Part 1. Highlights Ophthalmol 2005; 33:7-8.
6. Mahar PS, Nwokora GE. Role of mitomycin-C in pterygium surgery. Br J Ophthalmol 1993; 77:433-5.
7. Rachmiel R, Leiba H, Levartovsky S. Results of treatment with topical mitomycin-C 0.02% following excision of primary pterygium. Br J Ophthalmol 1995; 79:233-6.
8. Cano-Parra J, Diaz-Llopis M, Maldonado MJ, Vila E, Menezo JL. Prospective trial of intraoperative mitomycin-C in the treatment of primary pterygium. Br J Ophthalmol 1995; 79:439-41.
9. Boyd S. Application of mitomycin-C during pterygium surgery. Highlights Ophthalmol 2002; 30: 26.
10. Mastropasqua L, Carpineto P, Ciancaglini M, Enrico Gallenga P. Long-term results of intraoperative mitomycin-C in the treatment of recurrent pterygium. Br J Ophthalmol 1996; 80: 288-91.
11. Amano S, Motoyama Y, Oshika T, Eguchi S, Eguchi K. Comparative study of intraoperative mitomycin-C and β-irradiation in pterygium surgery. Br J Ophthalmol 2000; 84: 618-21.
12. Raiskup F, Solomon A, Landau D, Ilsar M, Frunch Pery J. mitomycin-C for pterygium: long-term evaluation. Br J Ophthalmol 2004; 88:1425-8.
13. Avisar R, Gaton D, Loya N, Appel I, Weinberger D. Intraoperative mitomycin-C 0.02% for pterygium: effect of duration of application on recurrence rate. Cornea 2003; 22:102-4.
14. Frucht-Pery J, Raiskup F, Ilsar M, Landau D, Qrucov F, Solomon A. Conjunctival autografting combine with low dose mitomycin-C for prevention of primary pterygium recurrence. Am J Ophthalmol 2006; 141:1044-50.
15. Fahmi MS, Sayed J, Ali M. After removal of pterygium role of mitomycin and conjunctival autograph. Ann Abbasi Shaheed Hosp Kar Med Dent Coll 2005; 10:257-61.